Skip to main content

Peer Review reports

From: The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study

Original Submission
11 Feb 2022 Submitted Original manuscript
11 May 2022 Reviewed Reviewer Report
16 Aug 2022 Reviewed Reviewer Report - T Milota
14 Sep 2022 Author responded Author comments - Ingrid Egeland Christensen
Resubmission - Version 2
14 Sep 2022 Submitted Manuscript version 2
19 Sep 2022 Reviewed Reviewer Report
25 Sep 2022 Reviewed Reviewer Report - T Milota
28 Sep 2022 Author responded Author comments - Ingrid Egeland Christensen
Resubmission - Version 3
28 Sep 2022 Submitted Manuscript version 3
Publishing
28 Sep 2022 Editorially accepted
5 Oct 2022 Article published 10.1186/s12916-022-02587-8

You can find further information about peer review here.

Back to article page